Novavax (NVAX)
(Delayed Data from NSDQ)
$13.01 USD
-1.39 (-9.65%)
Updated May 17, 2024 04:00 PM ET
After-Market: $13.01 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.87 | 7.16% |
Earnings Summary
For their last quarter, Novavax (NVAX) reported earnings of -$1.05 per share, missing the Zacks Consensus Estimate of -$1.04 per share. This reflects a negative earnings surprise of 0.96%. Look out for NVAX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.87 per share, reflecting a year-over-year decrease of 250%.
Earnings History
Price & Consensus
Zacks News for NVAX
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
NVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services